関連する実験動画
Updated: Jul 26, 2026

07:27
Implantation of Total Artificial Heart in Congenital Heart Disease
Published on: July 18, 2014
まとめ
心臓病の患者では,重度の作業負荷の増加にもかかわらず,左心室の効率は正常に留まることがあります. 心筋の酸素消費量 (MVO2) は,これらの条件下における心室の働きと直接関連していません.
科学分野:
- 心臓病学 心臓病学
- 心血管生理学 心血管の生理学
- バイオメディカルエンジニアリング
背景:
- 弁や心筋疾患は,心臓機能に重大な影響を及ぼします.
- 心筋の酸素消費量 (MVO2) と心室効率の評価は,疾患の進行を理解するために重要である.
研究 の 目的:
- 左心室の効率,心筋機能,および弁または心筋疾患の患者における酸素消費との関係を調査する.
- 作業量が増加したにもかかわらず,左心室の効率が維持されているかどうかを判断する.
主な方法:
- 心臓キャセテリゼーションは,弁膜および/または心筋疾患を有する38人の成人に実施されました.
- 冠動脈の血流と心筋のO2消費量 (MVO2) は,酸化窒素洗浄技術を使用して測定されました.
- 定量的二平面動脈造影は,左心室の体積,質量,射出分数,および作業を評価した.
主要な成果:
- 左心室の効率は4%から40%に変化し,重度の圧力-体積過負荷下にある一部の患者では正常な効率が観察されました.
- 総MVO2も,100gあたりのMVO2も,心室作業,放出分数,または張力時間指数との有意な相関を示さなかった.
- 休息中の心室の代謝需要の慢性的な増加は,MVO2が100gあたり増加するよりむしろ,高縮によって補償されるように見える.
結論:
- 左心室の効率は,慢性弁または心筋疾患における心筋機能に関連しています.
- ハイパルトロフィーされた心室は,正常な効率を示し得る.
- 慢性疾患における心筋の酸素需要の増加は,高縮によって満たされ,MVO2が100gあたり上昇することはありません.
関連する概念動画
Imbalances in Cardiac Output
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Cardiac Catheterization III: Left Heart Catheterization
Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...
Mitral Regurgitation I: Introduction
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Mitral Stenosis I: Introduction
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...

